Valuation: IDEXX Laboratories, Inc.

Market Cap 4.09TCr 21TCr 3.59TCr 3.39TCr 3.09TCr 5.78TCr 3,92100Cr 5.82TCr 41TCr 16TCr 2,00300Cr 15TCr 15TCr 6,43800Cr P/E 2026 *
35.2x
P/E 2027 * 31.1x
Enterprise Value 4.13TCr 21TCr 3.62TCr 3.42TCr 3.12TCr 5.84TCr 3,95600Cr 5.88TCr 41TCr 16TCr 2,02100Cr 15TCr 15TCr 6,49600Cr EV / Sales 2026 *
8.74x
EV / Sales 2027 * 7.94x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -
1 day-7.05%
1 week+1.91%
Current month-6.00%
1 month-7.05%
3 months-6.84%
6 months-10.65%
Current year-28.76%
1 week 538.1
Extreme 538.1
538.1
1 month 522.12
Extreme 522.12
548
Current year 521.5
Extreme 521.5
773.97
1 year 521.5
Extreme 521.5
813.6
3 years 438.17
Extreme 438.17
813.6
5 years 336.6
Extreme 336.6
813.6
10 years 225.06
Extreme 225.055
813.6
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO 43 01/03/2025
Chief Operating Officer 58 01/01/2025
Director TitleAgeSince
Chairman 65 12/05/2026
Director/Board Member 64 15/07/2013
Director/Board Member 73 11/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
-7.05%+1.91% - - 4.09TCr
+1.14%+1.49%-16.00%+18.76% 4.09TCr
Average -2.96%+1.49%-16.00%+18.76% 4.09TCr
Weighted average by Cap. -2.96%+1.49%-16.00%+18.76%

Financials

2026 *2027 *
Net sales 472.26Cr 2.46TCr 414.4Cr 391.39Cr 356.68Cr 667.68Cr 45TCr 672.44Cr 4.68TCr 1.81TCr 23TCr 1.77TCr 1.73TCr 74TCr 514.09Cr 2.67TCr 451.11Cr 426.06Cr 388.27Cr 726.82Cr 49TCr 732.01Cr 5.1TCr 1.97TCr 25TCr 1.93TCr 1.89TCr 81TCr
Net income 117.89Cr 612.98Cr 103.45Cr 98Cr 89Cr 166.67Cr 11TCr 167.86Cr 1.17TCr 452.84Cr 5.77TCr 442.63Cr 433.06Cr 19TCr 131.46Cr 683.55Cr 115.36Cr 108.95Cr 99Cr 185.86Cr 13TCr 187.19Cr 1.3TCr 504.97Cr 6.44TCr 493.59Cr 482.91Cr 21TCr
Net Debt 37Cr 191.34Cr 32Cr 30Cr 28Cr 52Cr 3.53TCr 52Cr 364.95Cr 141.35Cr 1.8TCr 138.17Cr 135.18Cr 5.79TCr -9.73Cr -51Cr -8.54Cr -8.07Cr -7.35Cr -14Cr -932.93Cr -14Cr -97Cr -37Cr -476.62Cr -37Cr -36Cr -1.53TCr
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
25/26/25 R$538.10 +1.91% 21
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
519.26USD
Average target price
701.33USD
Spread / Average Target
+35.06%

Quarterly revenue - Rate of surprise